Variant Synonymizer: Platform to identify mutations defined in different ways is available now!
Over 2,000 gene–disease validation summaries are now available—no login required!
NDUFB11 encodes an accessory subunit of mitochondrial respiratory chain complex I, essential for assembly and function of NADH:ubiquinone oxidoreductase. Variants in NDUFB11 have been identified in patients presenting with a spectrum of mitochondrial disease (MD) manifestations, including lactic acidosis, cardiomyopathy, and complex I deficiency, consistent with the broad phenotypic heterogeneity of MONDO:0044970 (NDUFB11; mitochondrial disease).
NDUFB11-related MD follows an X-linked inheritance pattern, with hemizygous or de novo nonsense and missense variants identified in 10 unrelated probands across five studies. One patient with an NDUFB11 variant was diagnosed by WES in an Estonian MD cohort ([PMID:30009132]). A de novo nonsense variant c.262C>T (p.Arg88Ter) was reported in a female with histiocytoid cardiomyopathy and overlaps with a case of microphthalmia with linear skin defects ([PMID:28050600]). Two male patients harbored de novo hemizygous missense variants c.286T>C (p.Ser96Pro) and c.361G>A (p.Glu121Lys) presenting lactic acidosis and hypertrophic cardiomyopathy ([PMID:30423443]), one neonatal lethal case carried c.338G>A (p.Arg113Lys) affecting splicing ([PMID:36675256]), and a recurring in‐frame deletion c.276_278del (p.Phe93del) was observed in five males with sideroblastic anemia and complex I instability ([PMID:27488349]). No segregation data are available.
Reported pathogenic variants include nonsense (n = 2), missense (n = 4), in-frame deletion (n = 1), and splice-altering substitutions (n = 1). Recurrent p.Phe93del was seen in a founder cohort of X-linked sideroblastic anemia. The c.262C>T (p.Arg88Ter) truncating allele has been observed in two unrelated cases, indicating recurrence at CpG dinucleotides.
Patient-derived fibroblasts and muscle biopsies show reduced NDUFB11 protein levels, impaired complex I assembly, and decreased NADH:ubiquinone oxidoreductase activity. Lentiviral complementation with wild-type NDUFB11 restores complex I function ([PMID:30423443]). Splicing assays confirmed that c.338G>A disrupts canonical transcript expression and leads to a nonfunctional alternative isoform ([PMID:36675256]). The p.Phe93del allele induces complex I instability and reduced activity in K562 cells, recapitulating mitochondrial respiratory defects ([PMID:27488349]).
Collectively, the data support a loss-of-function mechanism via impaired complex I assembly. The consistent biochemical signature across multiple variant classes and rescue by complementation underpin the pathogenic role of NDUFB11 in mitochondrial disease. NDUFB11 should be included in MD gene panels, and WES/WGS can effectively detect both coding and splice-site variants.
Key Take-home: Hemizygous and de novo NDUFB11 loss-of-function variants cause X-linked mitochondrial disease with complex I deficiency, guiding diagnosis by sequencing and functional assays.
Gene–Disease AssociationStrong10 unrelated hemizygous or de novo probands with NDUFB11 variants causing complex I deficiency and broad mitochondrial disease phenotype; concordant functional data Genetic EvidenceStrong10 probands with de novo or hemizygous variants across five studies reaching the genetic evidence cap ([PMID:30009132]; [PMID:28050600]; [PMID:30423443]; [PMID:36675256]; [PMID:27488349]) Functional EvidenceStrongBiochemical assays show impaired complex I activity and assembly in patient cells and rescue by complementation; splicing models demonstrate pathogenic transcript effects |